Evidence for anti-inflammatory effects of firocoxib administered to mares with experimentally induced placentitis.

Abstract

Minimal evidence exists supporting therapeutic selections for equine placentitis. The goal of this study was to characterize the anti-inflammatory effects of firocoxib when administered to mares with placentitis. Mares (gestation D270-300) were assigned to: INFECT (n=6; placentitis, no treatment), FIRO (n=6; placentitis, firocoxib, 0.1mg/kg, PO, daily), and NORM (n=6; no infection/treatment). Allantoic fluid (8hours, 24hours, birth) and amniotic fluid (birth) were collected from mares after infection. Concentrations of IL-1β, IL-6, TNF-α, IL-10, PGF2α , and PGE2 in fluids were measured by ELISA. mRNA expression of IL-1β, IL-6, TNF-α, IL-8, IL-10, matrix metalloproteinases (MMPs) -1, 3, and 9 in fetal membranes/fetuses was quantified using real-time PCR. Allantoic TNF-α concentrations were lowest in FIRO at 8hours and 24hours post-infection; IL-6 concentrations were lower in FIRO than NORM at 8hours, lower in FIRO than INFECT at 24hours post-inoculation, and lower in NORM than FIRO or INFECT at birth. Marginal mean allantoic IL-β and IL-10 concentrations were lower in FIRO and NORM than INFECT. Amniotic fluid cytokines were lowest in NORM with all measurements in that group being below the limit of detection. Allantoic PGF2α concentrations were lower in FIRO and INFECT than NORM at 8hours post-inoculation, and lower in FIRO than INFECT or NORM at 24hours post-inoculation. Allantoic PGE2 concentrations were lower in FIRO than INFECT. Amniotic PGF2α and PGE2 concentrations were lower in NORM than INFECT. In fetal membranes, group differences with respect to IL-1β, IL-6, IL-8, and MMP1 were dependent on tissue type. Data suggest a suppressive effect of firocoxib administration on cytokine and prostaglandin production in mares with placentitis.